Good Laboratory Practice (GLP) is a formal quality system that governs the organisational processes and conditions under which non‑clinical health and environmental safety studies are planned, performed, monitored, recorded, archived, and reported. Established initially by the OECD in 1981, GLP has since become the international gold standard for ensuring the reliability and integrity of data generated from laboratory studies.
Why GLP Exists and What It Achieves
The primary objective of GLP is to ensure that test data submitted to regulatory authorities are of high quality, reproducible, and truly reflective of the safety profile of chemical substances, pharmaceuticals, and other products. When a laboratory operates under GLP, the data it produces is accepted by regulatory bodies across OECD member countries under the Mutual Acceptance of Data (MAD) framework. This means that a study conducted in a GLP‑compliant facility in one country can be used for regulatory submissions in another – a significant advantage for global pharmaceutical and chemical companies.
The FDA and OECD Frameworks
In the United States, GLP compliance is mandated under 21 CFR Part 58, which prescribes good laboratory practices for conducting non‑clinical laboratory studies that support or are intended to support applications for research or marketing permits for FDA‑regulated products. This regulation covers everything from facility organisation and personnel qualifications to equipment calibration, test article handling, record retention, and quality assurance. The FDA conducts hundreds of inspections annually, and non‑compliance can lead to severe enforcement actions.
Internationally, the OECD Principles of GLP serve as the harmonised standard, adopted by over 30 member countries. These principles establish quality standards for the organisation and management of test facilities and guide the conduct and reporting of studies related to the safety of chemical substances. Both frameworks share common goals – reliability, traceability, and integrity – though professionals working globally must understand the nuances of each.
Who Needs GLP Compliance?
GLP applies to any laboratory conducting non‑clinical safety studies for regulatory submission – including contract research organisations (CROs), pharmaceutical R&D labs, chemical manufacturers, agricultural testing facilities, and medical device companies. Study directors, quality assurance personnel, analysts, and archivists must all be thoroughly trained in GLP principles to ensure that every study meets the required standards.
The Consequences of Non‑Compliance
A single GLP violation can result in the rejection of an entire study, regulatory warning letters, product approval delays, and significant financial losses. Beyond regulatory penalties, the loss of reputation and client trust can be devastating. That is why continuous education and hands‑on training in GLP are not optional – they are essential for survival in the regulated industry.
🎓 Master GLP with GxP Trainings – Four Specialized Programs
We offer four distinct training tracks to meet every professional need. Whether you are new to GLP, seeking formal certification, or aiming to become a qualified internal auditor, we have the right course for you.
| Program | Focus | Link |
|---|---|---|
| OECD GLP Foundation | OECD Principles – comprehensive coverage of study conduct, QA, and SOPs. | Enroll Now |
| FDA GLP Compliance | 21 CFR Part 58 – detailed training on FDA expectations for non‑clinical labs. | Enroll Now |
| OECD GLP Internal Auditor | ISO 19011‑based auditing for OECD GLP – plan, conduct, and report internal audits. | Enroll Now |
| FDA GLP Internal Auditor | Internal auditing specifically for FDA 21 CFR Part 58 environments. | Enroll Now |
Choose your path, gain recognised credentials, and elevate your laboratory compliance expertise today!
Contact GxP Trainings | Life Sciences Training Support
Authors
